These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 26458482)

  • 1. Intravitreal aflibercept for management of subfoveal choroidal neovascularization secondary to angioid streaks.
    Esen E; Sizmaz S; Demircan N
    Indian J Ophthalmol; 2015 Jul; 63(7):616-8. PubMed ID: 26458482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching from ranibizumab to aflibercept in choroidal neovascularization secondary to angioid streaks.
    Sekfali R; Mimoun G; Cohen SY; Querques G; Bandello F; Sacconi R; Souied EH; Capuano V
    Eur J Ophthalmol; 2020 May; 30(3):550-556. PubMed ID: 30880436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up.
    Tilleul J; Mimoun G; Querques G; Puche N; Zerbib J; Lalloum F; Srour M; Souied EH
    Retina; 2016 Mar; 36(3):483-91. PubMed ID: 26355947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal aflibercept for refractory choroidal neovascularization secondary to angioid streaks.
    Tetikoglu M; Sagdik HM; Aktas S; Ozcura F
    Eye (Lond); 2016 Jun; 30(6):894-5. PubMed ID: 26939555
    [No Abstract]   [Full Text] [Related]  

  • 5. Aflibercept for choroidal neovascularizations secondary to pseudoxanthoma elasticum: a prospective study.
    Gliem M; Birtel J; Herrmann P; Fimmers R; Berger M; Coch C; Wingen A; Holz FG; Charbel Issa P
    Graefes Arch Clin Exp Ophthalmol; 2020 Feb; 258(2):311-318. PubMed ID: 31863395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treat and extend regimen with aflibercept for choroidal neovascularization in angioid streaks.
    Diago T
    Eye (Lond); 2016 Apr; 30(4):637-9. PubMed ID: 26795418
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravitreal aflibercept for management of choroidal neovascularization secondary to angioid streaks : The Italian EYLEA-STRIE study.
    Parodi MB; Cicinelli MV; Marchese A; Giuffrè C; Viola F; Staurenghi G; Varano M; Bandello F
    Eur J Ophthalmol; 2021 May; 31(3):1146-1153. PubMed ID: 32483995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience of switching anti-VEGF therapy from ranibizumab to aflibercept in age-related choroidal neovascularization.
    Van Lancker L; Petrarca R; Moutsouris K; Masaoutis P; Kampougeris G
    Eur J Ophthalmol; 2017 May; 27(3):342-345. PubMed ID: 27739561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Follow-Up of Choroidal Neovascularization due to Angioid Streaks with pro re nata Intravitreal Anti-VEGF Treatment.
    Giacomelli G; Finocchio L; Biagini I; Sodi A; Murro V; Introini U; Varano M; Bandello F; Menchini U
    Ophthalmologica; 2017; 238(1-2):44-51. PubMed ID: 28641290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal ranibizumab for choroidal neovascularization in angioid streaks.
    Mimoun G; Tilleul J; Leys A; Coscas G; Soubrane G; Souied EH
    Am J Ophthalmol; 2010 Nov; 150(5):692-700.e1. PubMed ID: 20719301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal aflibercept for myopic choroidal neovascularization.
    Pece A; Milani P
    Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2327-2332. PubMed ID: 27286893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue therapy with intravitreal aflibercept for choroidal neovascularization secondary to choroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab.
    Saitta A; Nicolai M; Neri P; Reibaldi M; Giovannini A; Mariotti C
    Int Ophthalmol; 2015 Jun; 35(3):441-4. PubMed ID: 25761547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravitreal injection of aflibercept or ranibizumab on chorioretinal atrophy in myopic choroidal neovascularization.
    Sayanagi K; Uematsu S; Hara C; Wakabayashi T; Fukushima Y; Sato S; Ikuno Y; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):749-757. PubMed ID: 30643966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal aflibercept for the treatment of choroidal neovascularization associated with rubella retinopathy.
    Kiziltoprak H; Yetkin E; Tekin K; Koc M; Akalin İ; Teke MY
    Int Ophthalmol; 2019 Feb; 39(2):477-484. PubMed ID: 29411259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Sakurada Y; Sugiyama A; Tanabe N; Kikushima W; Kume A; Iijima H
    Retina; 2017 Oct; 37(10):1866-1872. PubMed ID: 28002268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-Year Outcomes of the Treat-and-Extend Approach with Aflibercept in Age-Related Macular Degeneration: Effects on Typical Choroidal Neovascularization and Retinal Angiomatous Proliferation.
    Castro-Navarro V; Cervera-Taulet E; Montero-Hernández J; Navarro-Palop C
    Ophthalmologica; 2016; 236(4):215-222. PubMed ID: 27997921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration.
    Yun C; Oh J; Ahn J; Hwang SY; Lee B; Kim SW; Huh K
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1693-702. PubMed ID: 26781585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination treatment with intravitreal injection of ranibizumab and reduced fluence photodynamic therapy for choroidal neovascularization secondary to angioid streaks: preliminary clinical results of 12-month follow-up.
    Artunay O; Yuzbasioglu E; Rasier R; Sengul A; Senel A; Bahcecioglu H
    Retina; 2011; 31(7):1279-86. PubMed ID: 21394063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY.
    Sarao V; Parravano M; Veritti D; Arias L; Varano M; Lanzetta P
    Retina; 2016 Apr; 36(4):770-7. PubMed ID: 26398691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in choroidal thickness after intravitreal injection for treatment of neovascular age-related macular degeneration: Ranibizumab versus aflibercept.
    Kaya F
    J Fr Ophtalmol; 2017 Dec; 40(10):832-838. PubMed ID: 29113742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.